OncoTherapy Science: 1st quarter financial results SMS for the March 2025 period based on Japanese standards (consolidated).
OncoTherapy Science: Announcements of individual stocks regarding the occurrence of non-operating expenses.
OncoTherapy Science: Interim report
OncoTherapy Science: Confirmation letter
OncoTherapy Science: Financial Report - Term 23 (2023/04/01 - 2024/03/31)
ONCOTHERAPY SCIENCE: Notice regarding differences between consolidated financial results for the fiscal year ending March 31, 2024 and results for the previous fiscal year
ONCOTHERAPY SCIENCE: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Oncotherapy Science: Extraordinary Report
Oncotherapy Science: Confirmation
Oncotherapy Science: Quarterly Report - 23rd Quarter 3rd Quarter (2023/10/01 - 2023/12/31)
OncoTherapy Science: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
OncoTherapy Science: Confirmation letter
OncoTherapy Science: Quarterly Report - 23rd Second Quarter (2023/07/01 - 2023/09/30)
OncoTherapy Science: Summary of Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
OncoTherapy Science: Confirmation letter
OncoTherapy Science: Quarterly Report - First Quarter 23 (2023/04/01 - 2023/06/30)
OncoTherapy Science: Summary of Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
OncoTherapy Science: Confirmation letter
OncoTherapy Science: Securities Report - 22nd Period (2022/04/01 - 2023/03/31)
OncoTherapy Science: Notice Concerning the Difference Between Consolidated Financial Results for the Fiscal Year Ending March 31, 2023 and the Results of the Previous Fiscal Year
No Data
No Data